Literature DB >> 9777418

MASP-2, the C3 convertase generating protease of the MBLectin complement activating pathway.

T Vorup-Jensen1, J C Jensenius, S Thiel.   

Abstract

Mannan-binding lectin (MBL) activates the complement system through cleavage of C4 and C2. Until recently it was thought that only one serine protease in complex with MBL (MBL-associated serine protease, MASP) mediates complement activation, but with the finding of a second MBL-associated serine protease, MASP-2, the activation process appears more elaborate, possibly resembling that of the C1 complex. The two MASPs share the domain organisation of C1r and C1s and it may be speculated that interaction between the two MASPs is required for complement activation in the same manner as with the C1 proteases. We have demonstrated that MASP-2 is a C4 cleaving component of the MBL/MASP complex. By analogy, one may thus speculate that, upon binding of MBL to carbohydrate, MASP-1 autoactivates and then activates MASP-2, but there is as yet no evidence for this. The components of C1 are present in serum in approximately equimolar amounts, whereas MASP-1 is in large excess over MBL. Pairwise comparison of the four proteases shows the primary structures to be approximately 40% identical. Phylogenetic analysis indicates that MASP-2 is closer to C1r and C1s than is MASP-1, but no particular association between MASP-2 and the C4 cleaving enzyme, C1s, can be deduced from sequence comparison.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9777418     DOI: 10.1016/S0171-2985(98)80039-9

Source DB:  PubMed          Journal:  Immunobiology        ISSN: 0171-2985            Impact factor:   3.144


  12 in total

Review 1.  Mannan-binding-lectin-associated serine proteases, characteristics and disease associations.

Authors:  Rikke Sørensen; Steffen Thiel; Jens C Jensenius
Journal:  Springer Semin Immunopathol       Date:  2005-11-11

2.  Intracellular survival of Leishmania major in neutrophil granulocytes after uptake in the absence of heat-labile serum factors.

Authors:  Helmut Laufs; Kerstin Müller; Jens Fleischer; Norbert Reiling; Nicole Jahnke; Jens C Jensenius; Werner Solbach; Tamás Laskay
Journal:  Infect Immun       Date:  2002-02       Impact factor: 3.441

3.  Studies of the pattern recognition molecule H-ficolin: specificity and purification.

Authors:  Rikke M Zacho; Lisbeth Jensen; Randi Terp; Jens C Jensenius; Steffen Thiel
Journal:  J Biol Chem       Date:  2012-01-11       Impact factor: 5.157

4.  Mechanism of complement-dependent haemolysis via the lectin pathway: role of the complement regulatory proteins.

Authors:  C Suankratay; C Mold; Y Zhang; T F Lint; H Gewurz
Journal:  Clin Exp Immunol       Date:  1999-09       Impact factor: 4.330

5.  Enhancement of lectin pathway haemolysis by immunoglobulins.

Authors:  C Suankratay; Y Zhang; D Jones; T F Lint; H Gewurz
Journal:  Clin Exp Immunol       Date:  1999-09       Impact factor: 4.330

6.  Loa loa Microfilariae evade complement attack in vivo by acquiring regulatory proteins from host plasma.

Authors:  Karita Haapasalo; Taru Meri; T Sakari Jokiranta
Journal:  Infect Immun       Date:  2009-06-15       Impact factor: 3.441

7.  Localized-statistical quantification of human serum proteome associated with type 2 diabetes.

Authors:  Rong-Xia Li; Hai-Bing Chen; Kang Tu; Shi-Lin Zhao; Hu Zhou; Su-Jun Li; Jie Dai; Qing-Run Li; Song Nie; Yi-Xue Li; Wei-Ping Jia; Rong Zeng; Jia-Rui Wu
Journal:  PLoS One       Date:  2008-09-16       Impact factor: 3.240

8.  Continual low-level activation of the classical complement pathway.

Authors:  A P Manderson; M C Pickering; M Botto; M J Walport; C R Parish
Journal:  J Exp Med       Date:  2001-09-17       Impact factor: 14.307

Review 9.  Science review: key inflammatory and stress pathways in critical illness - the central role of the Toll-like receptors.

Authors:  Bruce Beutler
Journal:  Crit Care       Date:  2002-09-18       Impact factor: 9.097

10.  Mannan-binding lectin in cerebrospinal fluid: a leptomeningeal protein.

Authors:  Hansotto Reiber; Barbara Padilla-Docal; Jens Christian Jensenius; Alberto Juan Dorta-Contreras
Journal:  Fluids Barriers CNS       Date:  2012-08-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.